GLENN MILLER
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
JONATHAN BILZIN,
GAVIN CHITTICK,
MICHAEL KARANGELEN,
MICHAEL LAMBERT,
CHARLEY MOSS,
PETER NELSON,
TRAVIS NELSON,
ARTHUR, III STARRS,
THOMAS W. STEPHENSON, JR.,
BRADLEY K. WARDLOW
EXECUTIVE OFFICER
NORMAN G BENSON,
GERALD F CLARK,
A WAYNE CURZADD,
A. WAYNE CURZADD,
JOHN W HARKINS,
JOHN W. HARKINS,
MICHAEL J HIBBERD,
MICHAEL J. HIBBERD,
DONALD R. INGRAM,
RICHARD E MACDOUGAL,
RICHARD E. MACDOUGAL,
GARRY P MIHAICHUK,
GARRY P. MIHAICHUK,
JANET A. NUSSBAUM,
CHRISTOPER C. RIVETT-CARNAC,
RICHARD E. RIVETT-CARNAC,
ALEX T WARMATH,
ALEX T. WARMATH,
MARK N. WITT
DIRECTOR
SCOTT ALLOCCO,
PAUL BERESFORD,
SAM BRODER,
CY CABRADILLA,
DOUGLAS CLARK,
JACK DAVIS,
JOSEPH KLEIN,
KATARZYNA KUSMIERZ,
KAREN OLSON,
KAREN MARIE OLSON,
JERRY PARROTT,
JASON RUBIN,
MARK VELLECA,
CHRISTINA WYSKIEL,
CHRISTINE WYSKIEL
EXECUTIVE OFFICER
JERRY BRYANT,
DAVID DEL ZOPPO,
RICHARD EKSTRAND,
ALAN GRUNDEI,
STEVEN R. HAGSTROM,
GREG JENSEN,
WILLIAM JOHNSON,
DAVE KONLE,
DAVID KONLE,
WAYNE MARTIN,
GLEN MILLER,
JOE NILAN,
MIKE PFEIFFER,
JEFF SEIDEL,
JEFF SEIDL,
GARY SKORDAHL,
SAM TRIPLETT,
JUSTIN ZAVADIL,
LARRY ZAVADIL,
LARRY A. ZAVADIL
EXECUTIVE OFFICER
JEFF ANDREWS,
CHRISTOPHER BISHOP,
CHRISTA BLUMENSHINE,
JOSEPH T. CLARK,
KENDALL HAGOOD,
ERIK KRAEMER,
MATTHEW LAU,
TRAVIS MESSINA,
GREG MILLER,
RILEY ORR,
ROBERT RYAN,
RUSTY STRANGE,
MELISSA SZABAD,
KATIE TURNER,
ROBB WEBB
EXECUTIVE OFFICER
JACK AZAGURY,
JONATHAN BILZIN,
GARY BRUEBAKER,
JOHN CONNOLLY,
JOHN CONNOLY,
KAREN DAHUT,
DAVID HOLTZE,
KORHAN KIVANC,
CHRISTOPHER LOIACONO,
SHARI SAVITT,
JOSEPH SINICROPI,
WALTER WEIL,
CHARLES WEINSTEIN,
JAY WEINSTEIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER
DECLINE TO DISCLOSE
Equity
2026-03-14
D/A
OTHER
DECLINE TO DISCLOSE
Equity
2021-03-03
D
OTHER
DECLINE TO DISCLOSE
Equity
2021-03-03
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2016-08-23
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-08-18
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-11-22
D
OTHER
OVER $100,000,000
Debt
2013-03-29
D
OTHER
DECLINE TO DISCLOSE
Equity
2012-11-30
D
OTHER
DECLINE TO DISCLOSE
Equity
2012-03-26
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2011-08-09
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2011-08-09
D
OIL AND GAS
$1,000,001 - $5,000,000
Equity
2010-11-16
D
OIL AND GAS
$1,000,001 - $5,000,000
Equity
2010-09-14
D
OIL AND GAS
$1,000,001 - $5,000,000
Equity
2010-02-24
D
DECLINE TO DISCLOSE
Equity
2009-12-18
